Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Nanotechnology May Help Overcome Current Limitations of Gene Therapy
Uncategorized

Nanotechnology May Help Overcome Current Limitations of Gene Therapy

By medwebApr 1, 2003
Share
Facebook Twitter Email

April 18, 2003

Broadcast Media: Tamara Kerrill Field at (847) 491-4888 or at
tlk@northwestern.edu

Nanotechnology May Help Overcome Current Limitations of Gene Therapy

CHICAGO— Scientists from Northwestern University’s Feinberg School of Medicine and Argonne National Laboratory have created a hybrid “nanodevice” composed of a “scaffolding” of titanium oxide nanocrystals attached with snippets of DNA that may one day be used to target defective genes that play a role in cancer, neurological disease, and other conditions.

The titanium oxide nanocrystals, which are less than a few billionths of a meter in diameter and are the same material used in artificial hips and knees, may provide the ideal means of overcoming current limitations of gene therapy, such as adverse reactions to genetically modified viruses used as vehicles to deliver genes into cells, according to researchers Tatjana Paunesku, PhD, research assistant professor of radiology, and Gayle E. Woloschak, PhD, professor of radiology, at the Feinberg School. They are both researchers at The Robert H. Lurie Comprehensive Cancer Center of Northwestern University and Argonne National Laboratory.

In experiments described in the May online version of Nature Materials, the research team showed that nanocomposites not only retain the individual physical and biological activity of titanium oxide and of DNA but, importantly, also possess the unique property of separating when exposed to light or X rays.

For example, researchers would attach to the titanium oxide scaffolding a strand of DNA that matches a defective gene within a cell and introduce the nanoparticle into the nucleus of the cell, where the DNA would bind with its “evil twin” DNA strand to form a double-helix molecule.

The scientists would then expose the nanoparticle to light or X rays, which would snip off the defective gene.

“We call it a ‘Swiss army knife’ because, unlike today’s drugs, we can inject 10 kinds of good genes all at once and target them in extremely specific or extremely broad ways,” Dr. Paunesku said.

The titanium oxide “scaffolding” also is amenable to attaching other molecules, for example, navigational peptides, or proteins, which, like viral vectors, can help the nanoparticles home in on the cell nucleus.

The research group’s work is still in the early stages of development, and testing in a laboratory model is at least two years away, Dr. Woloschak said.

Also working on this project were Natasa S. Stojicevic of the medical school, and Tijana Rajh, Marion Thurnauer, Jorg Maser, Stefan Vogt, Gary Wiederrect, Miroslava Protic, Barry Lai, and Jeremy Oryhon of Argonne National Laboratory.

This study was supported by grants from the National Institutes of Health and the U.S. Department of Energy.

Share. Facebook Twitter Email

Related Posts

Mar 29, 2023

Adolescent Sexual Health Program Receives Funding for Social Marketing Campaign

Mar 29, 2023

Lurie Cancer Center Receives Merit Extension from NCI

Oct 20, 2021

Drug Combination May Reduce Risk of Leukemia Relapse

Mar 26, 2020

Comments are closed.

Latest News

Feinberg Investigators Identify How a Residential Neighborhood Can Impact Health

Sep 22, 2023

Robert Lamb, Renowned Expert on Influenza Virus, Dies at 72

Sep 22, 2023

Bethany Ekesa, Associate Director of SPARC, Honored with Jean E. Shedd University Citizenship Award

Sep 21, 2023

Combination Immunotherapy Shows No Additional Benefit for Most Advanced Cancers

Sep 21, 2023

Novel Intracellular Signaling Mechanisms Promote Melanoma Growth

Sep 21, 2023
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
20230914_NM461
20230914_NM644
20230914_NM345
20230914_NM444
20230914_NM464
20230914_NM520
20230914_NM673
20230914_NM641
20230914_NM612
20230914_NM608
20230914_NM602
20230914_NM597

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2023 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.